CRYO Cryo-Save

 

TIDMCRYO 
 
RNS Number : 8942M 
Cryo-Save Group NV 
02 June 2010 
 

2 June 2010 
 
Cryo-Save Group N.V. 
 
Cancellation of trading of Ordinary Shares on AIM 
 
Cryo-Save Group N.V. (AIM/Euronext: CRYO, 'Cryo-Save' or 'the Group'), announces 
that further to the statement made by the Group on 22 March 2010 regarding the 
intention to de-list its ordinary shares from trading on AIM, the Group today 
announces that its admission to trading on AIM will be cancelled with effect 
from 30 June 2010 (the "Cancellation") and that in accordance with Rule 41 of 
the AIM Rules, the Group has notified the London Stock Exchange of the 
Cancellation. 
 
Cryo-Save commenced dealing of its shares on Euronext Amsterdam (the "Euronext 
Listing") on 22 October 2009 and by virtue of the Group having a comparable 
dealing facility on Euronext Amsterdam, which is an EU Regulated market, 
shareholder approval for the Cancellation is not required. 
 
Background to and reasons for the Cancellation 
 
Following careful consideration, the Board has concluded that in light of the 
Group's listing on Euronext, it is no longer in the best interests of the Group 
or shareholders to maintain its admission to trading on AIM. Following its 
listing on Euronext in October 2009, Cryo-Save has had to adhere to two separate 
regulatory regimes which have both cost and resource implications for the Group. 
 The Directors feel that the cost and resource requirement of being an AIM 
quoted company alongside the Euronext listing does not provide the Group with 
significant additional benefit. 
 
The Directors believe that there will be limited impact on shareholders as a 
result of the Cancellation. Holders of the Depositary Interests ("DIs") that are 
currently traded on AIM will be able to continue to hold their DIs in CREST or 
convert these DIs into ordinary shares on Euronext Amsterdam. 
 
 
AIM shareholders 
 
As Cryo-Save is a non-UK incorporated company, UK shareholders currently hold 
their shares in the form of DIs which are settled through CREST. 
 
The Group intends to continue to allow its UK shareholders to hold their DIs in 
CREST. Therefore for those shareholders wishing to continue to maintain their 
holding/interest in Cryo-Save following the Cancellation, no action need be 
taken. 
 
Daniel Stewart and Company plc ("Daniel Stewart"), the Group's AIM nominated 
advisor and broker will remain the Group's UK broker following the Cancellation 
and in the event that UK DI holders wish to trade their Cryo-Save holdings 
either prior to or post the Cancellation, shareholders can continue to contact 
Daniel Stewart. 
 
A person currently holding shares in the form of DIs through CREST who wants to 
trade their shares on Euronext Amsterdam (and does not intend to continue to 
hold their DIs through CREST as set out above) must instruct Capita IRG Trustees 
Limited to cancel its DIs and transfer the underlying shares in book-entry form 
to the Qualifying ENL Account (see explanation below) which the relevant person 
needs to have or open as set out below. 
 
The cancellation of DIs in exchange for the underlying shares in book-entry form 
shall be effected by means of the submission of a duly completed CREST 
withdrawal form that can be obtained free of charge by contacting Capita IRG 
Trustees Limited on: +44 208 639 3135. 
 
 
Trading of Cryo-Save shares on Euronext Amsterdam 
 
Other than where DIs continue to be held in CREST by UK shareholders, shares 
traded on Euronext Amsterdam are settled in book-entry form through the 
book-entry facilities of Euroclear Nederland. The settlement and paying agent in 
relation to the Group's shares that are traded on Euronext Amsterdam is Kempen & 
Co N.V. 
 
Qualifying ENL Account 
A person who wants to trade their shares on Euronext Amsterdam must have or open 
an account, directly or by way of an intermediary, with an affiliated 
institution of Euroclear Nederland (such account, a "Qualifying ENL Account"). 
 
Persons holding shares in book-entry form 
A person holding shares in book-entry form within the book-entry facilities of 
Euroclear Nederland who wants to trade their shares on Euronext Amsterdam must 
instruct the affiliated institution that administers their Qualifying ENL 
Account or the intermediary (as applicable) accordingly. 
 
A person holding shares in registered form and who is registered on the Group's 
shareholder register who wants to trade their shares on Euronext Amsterdam must 
arrange for their shares to be included in the book-entry facilities of 
Euroclear Nederland. This inclusion shall be effected by means of the execution 
of a deed between the relevant person, Kempen & Co N.V. in its capacity as the 
settlement agent and ourselves. This deed can be obtained free of charge by 
sending a request for the deed in writing, by post, fax or e-mail to 
Cryo-Saveat: 
 
Cryo-Save Group N.V. 
IJsselkade 8 
7201 HB Zutphen 
The Netherlands 
 
fax: + 31 575 50 91 16 
e-mail: ir@cryo-save.com 
 
Alternatively, such deeds can be obtained free of charge by sending a request 
for the deed in 
writing, by post, fax or e-mail to Kempen & Co N.V.: 
 
Kempen & Co N.V. 
Beethovenstraat 300 
1077 WZ Amsterdam 
The Netherlands 
 
fax: + 31 20 348 9548 
e-mail: kas@kempen.nl 
 
Following the execution of the deed, the shares thus included in the book-entry 
facilities of 
Euroclear Nederland shall be credited to the Qualifying ENL Account which the 
relevant 
person needs to have or open as set out above. 
 
 
Enquiries: 
 
+-------------------------------------+----------------------+ 
| Cryo-Save Group                     | +  31 (0)575 548998  | 
+-------------------------------------+----------------------+ 
| Arnoud van Tulder, Chief Executive  |                      | 
| Officer                             |                      | 
|                                     |                      | 
+-------------------------------------+----------------------+ 
| Daniel Stewart & Company plc        | + 44 (0)20 7776 6550 | 
+-------------------------------------+----------------------+ 
| Simon Leathers/Emma Earl            |                      | 
+-------------------------------------+----------------------+ 
|                                     |                      | 
+-------------------------------------+----------------------+ 
| College Hill (UK)                   | + 44 (0)20 7457 2020 | 
+-------------------------------------+----------------------+ 
| Adrian Duffield/Rozi Morris         |                      | 
+-------------------------------------+----------------------+ 
|                                     |                      | 
+-------------------------------------+----------------------+ 
| Kempen & Co N.V                     |                      | 
+-------------------------------------+----------------------+ 
| Ivo Piest                           | +31 (0)20            | 
|                                     | 348 8511             | 
+-------------------------------------+----------------------+ 
|                                     |                      | 
+-------------------------------------+----------------------+ 
| SPJ Financiële Communicatie Amstelveen (NL)                | 
| +31 (0)20 647 8181                                         | 
+------------------------------------------------------------+ 
| Kees Jongsma/Léon Melens            |                      | 
+-------------------------------------+----------------------+ 
 
 
About Cryo-Savewww.cryo-savegroup.com 
 
With more than 130,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCQFLFBBQFBBBE 
 

Cryo-Save (LSE:CRYO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Cryo-Save (LSE:CRYO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024